Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response

被引:648
|
作者
Astuti, Indwiani [1 ]
Ysrafil [1 ]
机构
[1] Univ Gadjah Mada, Dept Pharmacol & Therapy, Fac Med Publ Hlth & Nurses, Yogyakarta 55281, Indonesia
关键词
COVID-19; SARS-CoV-2; Pandemic; ACE2; Wuhan; RECEPTOR-BINDING DOMAIN; SPIKE PROTEIN; IMMUNE-RESPONSES; SARS-COV; NEUTRALIZING ANTIBODIES; COVID-19; VACCINE; INFECTION; ENZYMES; TARGET;
D O I
10.1016/j.dsx.2020.04.020
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and aim: As a result of its rapid spread in various countries around the world, on March 11, 2020, WHO issued an announcement of the change in coronavirus disease 2019 status from epidemic to pandemic disease. The virus that causes this disease is indicated originating from animals traded in a live animal market in Wuhan, China. Severe Acute Respiratory Syndrome Coronavirus 2 can attack lung cells because there are many conserved receptor entries, namely Angiotensin Converting Enzyme-2. The presence of this virus in host cells will initiate various protective responses leading to pneumonia and Acute Respiratory Distress Syndrome. This review aimed to provide an overview related to this virus and examine the body's responses and possible therapies. Method: We searched PubMed databases for Severe Acute Respiratory Syndrome Coronavirus-2, Middle East respiratory syndrome-related coronavirus and Severe Acute Respiratory Syndrome Coronavirus. Full texts were retrieved, analyzed and developed into an easy-to-understand review. Results: We provide a complete review related to structure, origin, and how the body responds to this virus infection and explain the possibility of an immune system over-reaction or cytokine storm. We also include an explanation of how this virus creates modes of avoidance to evade immune system attacks. We further explain the therapeutic approaches that can be taken in the treatment and prevention of this viral infection. Conclusion: In summary, based on the structural and immune-evasion system of coronavirus, we suggest several approaches to treat the disease. (C) 2020 Diabetes India. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:407 / 412
页数:6
相关论文
共 50 条
  • [21] The liver in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection
    Davidov-Derevynko, Yana
    Ben Yakov, Gil
    Wieder, Anat
    Segal, Gad
    Naveh, Lior
    Orlova, Natalia
    Gringauz, Irina
    Amit, Sharon
    Mor, Orna
    Klempfner, Robert
    Rahav, Galia
    Ben Ari, Ziv
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 : E313 - E319
  • [22] JMM Profile: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
    Inglis, Timothy J. J.
    Mathee, Kalai
    JOURNAL OF MEDICAL MICROBIOLOGY, 2021, 70 (03)
  • [23] The liver in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection
    Davidov-Derevynko, Yana
    Ben Yakov, Gil
    Wieder, Anat
    Segal, Gad
    Naveh, Lior
    Orlova, Natalia
    Gringauz, Irina
    Amit, Sharon
    Mor, Orna
    Klempfner, Robert
    Rahav, Galia
    Ben Ari, Ziv
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 (1S) : E313 - E319
  • [24] Longitudinal Dynamics of the Neutralizing Antibody Response to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection
    Wang, Kai
    Long, Quan-Xin
    Deng, Hai-Jun
    Hu, Jie
    Gao, Qing-Zhu
    Zhang, Gui-Ji
    He, Chang-Long
    Huang, Lu-Yi
    Hu, Jie-Li
    Chen, Juan
    Tang, Ni
    Huang, Ai-Long
    CLINICAL INFECTIOUS DISEASES, 2021, 73 (03) : E531 - E539
  • [25] Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and glial cells: Insights and perspectives
    Vargas, Gabriele
    Geraldo, Luiz Henrique Medeiros
    Salomao, Natalia Gedeao
    Paes, Marciano Viana
    Lima, Flavia Regina Souza
    Gomes, Flavia Carvalho Alcantara
    BRAIN BEHAVIOR & IMMUNITY-HEALTH, 2020, 7
  • [26] Transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to animals: an updated review
    Sina Salajegheh Tazerji
    Phelipe Magalhães Duarte
    Parastoo Rahimi
    Fatemeh Shahabinejad
    Santosh Dhakal
    Yashpal Singh Malik
    Awad A. Shehata
    Juan Lama
    Jörn Klein
    Muhammad Safdar
    Md. Tanvir Rahman
    Krzysztof J. Filipiak
    Alfonso J. Rodríguez-Morales
    Md. Abdus Sobur
    Farrokhreza Kabir
    Bita Vazir
    Leonard Mboera
    Marco Caporale
    Md. Saiful Islam
    John H. Amuasi
    Rasha Gharieb
    Paola Roncada
    Sahar Musaad
    Bruno Tilocca
    Mohammad Kazem Koohi
    Ali Taghipour
    Ahmet Sait
    Kannan Subbaram
    Alireza Jahandideh
    Pejman Mortazavi
    Mohammad Amin Abedini
    David A. Hokey
    Unarose Hogan
    Mohamed N. F. Shaheen
    Ahmed Elaswad
    Mahmoud M. Elhaig
    Mohamed Fawzy
    Journal of Translational Medicine, 18
  • [27] Coinfection, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), and Influenza: An Evolving Puzzle
    Covin, Sara
    Rutherford, George W.
    CLINICAL INFECTIOUS DISEASES, 2021, 72 (12) : E993 - E994
  • [28] Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is likely to be androgen mediated
    Wambier, Carlos Gustavo
    Goren, Andy
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (01) : 308 - 309
  • [29] Posterior Oropharyngeal Saliva for the Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
    Wong, Sally Cheuk Ying
    Tse, Herman
    Siu, Hon Kei
    Kwong, Tsz Shan
    Chu, Man Yee
    Yau, Felix Yat Sun
    Cheung, Ingrid Yu Ying
    Tse, Cindy Wing Sze
    Poon, Kin Chiu
    Cheung, Kwok Chi
    Wu, Tak Chiu
    Chan, Johnny Wai Man
    Cheuk, Wah
    Lung, David Christopher
    CLINICAL INFECTIOUS DISEASES, 2020, 71 (11) : 2939 - 2946
  • [30] Association Between Duration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Positivity and Long COVID
    Pozzi, Chiara
    Sarti, Riccardo
    Levi, Riccardo
    Mollura, Maximiliano
    Azzolini, Elena
    Barbieri, Riccardo
    Mantovani, Alberto
    Rescigno, Maria
    CLINICAL INFECTIOUS DISEASES, 2023, 77 (11) : 1531 - 1533